Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo
  2. Suh, H. C.; Leeanansaksiri, W.; Ji, M.; Klarmann, K. D.; Renn, K.; Gooya, J.; Smith, D.; McNiece, I.; Lugthart, S.; Valk, P. J.; Delwel, R.; Keller, J. R.
  3. Oncogene. 2008, Sep 18; 27(42): 5612-5623.
  1. 2.   Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR
  2. Boyd, K. E.; Xiao, Y. Y.; Fan, K.; Poholek, A.; Copeland, N. G.; Jenkins, N. A.; Perkins, A. S.
  3. Blood. 2006, JAN 15; 107(2): 733-741.
  1. 3.   Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response
  2. Ji, Q. Y.; Gondek, D.; Hurwitz, A. A.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1456-1463.
  1. 4.   IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development
  2. Leeanansaksiri, W.; Wang, H.; Gooya, J. M.; Renn, K.; Abshari, M.; Tsai, S.; Keller, J. R.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 7014-7021.
  1. 5.   Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit
  2. Lennartsson, J.; Shivakrupa, R.; Linnekin, D.
  3. Journal of Biological Chemistry. 2004, OCT 22; 279(43): 44544-44553.
  1. 6.   Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils
  2. Kamohara, H.; Matsuyama, W.; Shimozato, O.; Abe, K.; Galligan, C.; Hashimoto, S. I.; Matsushima, K.; Yoshimura, T.
  3. Immunology. 2004 111(2): 186-194.
  1. 7.   Genetic control of myreloproliferation in BXH-2 mice
  2. Turcotte, K.; Gauthier, S.; Mitsos, L. M.; Shustik, C.; Copeland, N. G.; Jenkins, N. A.; Fournet, J. C.; Jolicoeur, P.; Gros, P.
  3. Blood. 2004 103(6): 2343-2350.
  1. 8.   Critical prosurvival roles for C/EBP beta and insulin-like growth factor I in macrophage tumor cells
  2. Wessells, J.; Yakar, S.; Johnson, P. F.
  3. Molecular and Cellular Biology. 2004 24(8): 3238-3250.
  1. 9.   Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: A randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma
  2. Smith, J. W.; Kurt, R. A.; Baher, A. G.; Denman, S.; Justice, L.; Doran, T.; Gilbert, T.; Alvord, W. G.; Urba, W. J.
  3. Journal of Immunotherapy. 2003 26(2): 130-138.
  1. 10.   A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma
  2. Janik, J. E.; Miller, L. L.; Korn, E. L.; Stevens, D.; Curti, B. D.; Smith, J. W.; Sznol, M.; Conlon, K. C.; Sharfman, W.; Urba, W. J.; Gause, B. L.; Longo, D. L.
  3. Blood. 2001 97(7): 1942-1946.
  1. 11.   Mechanisms for induction of acquired host immunity by neutrophil peptide defensins
  2. Lillard, J. W.; Boyaka, P. N.; Chertov, O.; Oppenheim, J. J.; McGhee, J. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(2): 651-656.
  1. 12.   The Ly-49 Family - Regulation of Cytokine Production in Murine Nk Cells
  2. Ortaldo, J. R.; Mason, L. H.; Gregorio, T. A.; Stoll, J.; Winklerpickett, R. T.
  3. Journal of Leukocyte Biology. 1997 62(3): 381-388.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel